Concepedia

Kellie S. Reynolds

KS

Statistics

Publications

14

Citations

617

H-Index

12

Active since

1998

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

University of Florida

Kellie S. Reynolds is an author at United States Food and Drug Administration specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

1998–2022

14

Publications

14

Predicting the Effect of Cytochrome P450 Inhibitors on Substrate Drugs: Analysis of Physiologically Based Pharmacokinetic Modeling Submissions to the US Food and Drug Administration

Christian Wagner, Yuzhuo Pan, Vicky Hsu et al. · Clinical Pharmacokinetics · 2014 · 145 citations

, , +17

Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation

Ping Zhao, Manuela de Lima Toccafondo Vieira, Joseph A. Grillo et al. · The Journal of Clinical Pharmacology · 2012 · 96 citations

, , +17

Quantitative Evaluation of Pharmacokinetic Inhibition of CYP3A Substrates by Ketoconazole: A Simulation Study

Ping Zhao, Isabelle Ragueneau‐Majlessi, Lei Zhang et al. · The Journal of Clinical Pharmacology · 2009 · 84 citations · Full text

, , +15

Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019

Jianghong Fan, Xinyuan Zhang, Jiang Liu et al. · Clinical Infectious Diseases · 2020 · 76 citations · Full text

, , +15

FDA Evaluations Using In Vitro Metabolism to Predict and Interpret In Vivo Metabolic Drug‐Drug Interactions: Impact on Labeling

Barbara M. Davit, Kellie S. Reynolds, Rae Yuan et al. · The Journal of Clinical Pharmacology · 1999 · 74 citations

, , +17

1–5 of 14